Literature DB >> 18592246

Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever.

Mehmet D Demirag1, Mehmet A Ozturk, Berna Goker, Seminur Haznedaroglu.   

Abstract

Articular attack is a common feature of familial Mediterranean fever (FMF). FMF arthritis commonly resolves without any sequale within a few weeks. However, approximately 10% of the patients develop protracted arthritis persisting for months to years. Treatment with colchicine may not be effective and nonsteroidal antiinflammatory drugs or second line agents may be needed for the management of protracted arthritis. In this paper, we describe a 22-year-old patient with FMF who was complicated with protracted arthritis in the knee and shoulder joints and bilateral sacroiliitis. He was successfully treated by intramuscular gold 50 mg weekly. However, gold treatment was discontinued 8 months later because of the development of asymptomatic proteinuria. In conclusion, FMF should be considered in the evaluation of peripheric oligoarthritis, particularly in patients with Mediterranean origin. Intramuscular gold might be an effective agent. However, care should be taken regarding the development of proteinuria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592246     DOI: 10.1007/s00296-008-0631-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

1.  Protracted familial Mediterranean fever arthritis.

Authors:  H Bodur; H Uçan; S Seçkin; U Seçkin; O H Gündüz
Journal:  Rheumatol Int       Date:  1999       Impact factor: 2.631

2.  Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis.

Authors:  Serdar Daysal; Gulhan Akcil; Berna Goker; Seminur Haznedaroglu; Nil Ercan; Mehmet Akif Ozturk
Journal:  Arthritis Rheum       Date:  2005-02-15

3.  Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis.

Authors:  Birol Balaban; Evren Yasar; Ahmet Ozgul; Kemal Dincer; Tunc Alp Kalyon
Journal:  Rheumatol Int       Date:  2005-02-12       Impact factor: 2.631

Review 4.  Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Işik Keleş; Gülümser Aydin; Aliye Tosun; Elem Inal; Hatice Keleş; Sevim Orkun
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

5.  Arthritis in children with familial Mediterranean fever.

Authors:  Erdal Ince; Nilgün Cakar; Mustafa Tekin; Tanil Kendirli; Nuray Ozkaya; Nejat Akar; Fatoş Yalçinkaya
Journal:  Rheumatol Int       Date:  2002-04       Impact factor: 2.631

Review 6.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

7.  Protracted arthritis of familial Mediterranean fever (an unusual complication).

Authors:  F Yalçinkaya; M Tekin; N Tümer; N Ozkaya
Journal:  Br J Rheumatol       Date:  1997-11

8.  Seronegative spondyloarthropathy in familial Mediterranean fever.

Authors:  P Langevitz; A Livneh; D Zemer; J Shemer; M Pras
Journal:  Semin Arthritis Rheum       Date:  1997-10       Impact factor: 5.532

9.  Seronegative spondyloarthropathy of familial Mediterranean fever.

Authors:  Nurgül Arinci Incel; Meryem Saraçoğlu; H Rana Erdem
Journal:  Rheumatol Int       Date:  2003-01       Impact factor: 2.631

10.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.